Veltassa Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

veltassa

vifor fresenius medical care renal pharma france - prostate sorbiteksa kalcij - hiperkalemija - zdravila za zdravljenje hyperkalemia in hyperphosphatemia - zdravilo veltassa je indicirano za zdravljenje hiperkaliemije pri odraslih.

Lopinavir/ritonavir Accord 200 mg/50 mg filmsko obložene tablete Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lopinavir/ritonavir accord 200 mg/50 mg filmsko obložene tablete

accord healthcare - ritonavir, lopinavir - filmsko obložena tableta - ritonavir 50 mg / 1 tableta; lopinavir 200 mg / 1 tableta - lopinavir in ritonavir

Lopinavir/ritonavir Accord 200 mg/50 mg filmsko obložene tablete Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lopinavir/ritonavir accord 200 mg/50 mg filmsko obložene tablete

accord healthcare - ritonavir, lopinavir - filmsko obložena tableta - ritonavir 50 mg / 1 tableta; lopinavir 200 mg / 1 tableta - lopinavir in ritonavir

Apixaban Accord Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

apixaban accord

accord healthcare s.l.u. - apixaban - venous thromboembolism; stroke; arthroplasty - antitrombotična sredstva - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery. preprečevanje kapi in sistemska embolija pri odraslih bolnikih z ne-valvular atrijsko fibrilacijo (nvaf), z eno ali več dejavnikov tveganja, kot so pred možgansko kap ali prehodni ischaemic napad (tia); starost ≥ 75 let; hipertenzija; sladkorna bolezen; simptomatsko srčno popuščanje (nyha razred ≥ ii). zdravljenje globoke venske tromboze (dvt) in pljučna embolija (pe), in preprečevanje ponavljajočih se dvt in pe pri odraslih (glej poglavje 4. 4 za haemodynamically nestabilno pe bolnikov). prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii). zdravljenje globoke venske tromboze (dvt) in pljučna embolija (pe), in preprečevanje ponavljajočih se dvt in pe pri odraslih (glej poglavje 4. 4 za haemodynamically nestabilno pe bolnikov).

Copiktra Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastična sredstva - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Sunlenca Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

sunlenca

gilead sciences ireland unlimited company - lenacapavir sodium - okužbe z virusom hiv - antivirusi za sistemsko uporabo - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 in 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 in 5.

Kaletra Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

kaletra

abbvie deutschland gmbh co. kg - lopinavir, ritonavir - okužbe z virusom hiv - antivirals for systemic use, protease inhibitors - zdravilo kaletra je indicirano v kombinaciji z drugimi protiretrovirusnimi zdravili za zdravljenje odraslih, mladostnikov in otrok, starih od 14 dni ali več, z virusom humane imunske pomanjkljivosti (hiv-1). izbira kaletra za zdravljenje protease inhibitor izkušeni hiv-1 okuženih bolnikov, ki mora temeljiti na posameznih virusnih odpornost testiranje in zdravljenje zgodovina bolnikov.

Lopinavir/Ritonavir Mylan Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

lopinavir/ritonavir mylan

mylan pharmaceuticals limited - lopinavir, ritonavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - lopinavir/ritonavir, ki je naveden v kombinaciji s drugih protiretrovirusna zdravila za zdravljenje virusom človeške imunske pomanjkljivosti (hiv-1) okuženih odrasli, mladostniki in otroci v starosti nad 2 leti. izbira lopinavir/ritonavir za zdravljenje protease inhibitor izkušeni hiv-1 okuženih bolnikov, ki mora temeljiti na posameznih virusnih odpornost testiranje in zdravljenje zgodovina bolnikov.